RIZ1, Recombinant, Human, aa2-200, GST-tag (KMT8, PRDM2, PR Domain Zinc Finger Protein 2, Retinoblastoma Protein-interacting Zinc Finger Protein)
Catalog No : USB-220232
406.91€
0.00€
Shipping cost plus VAT not included , delivery in 7-14 business days
| Product name | RIZ1, Recombinant, Human, aa2-200, GST-tag (KMT8, PRDM2, PR Domain Zinc Finger Protein 2, Retinoblastoma Protein-interacting Zinc Finger Protein) | ||
|---|---|---|---|
| Catalog No | USB-220232 | ||
| Supplier’s Catalog No | 220232 | ||
| Supplier | US Biologicals | ||
| Source antigen | Recombinant, E. coli | ||
| Reactivity | |||
| Cross reactivity | |||
| Applications | |||
| Molecular weight | 49.5 | ||
| Storage | -70°C | ||
|---|---|---|---|
| Other names | |||
| Grade | Highly Purified | ||
| Purity | ~95% (SDS-PAGE) | ||
| Form | Supplied as a liquid in 50mM Tris, pH 7.5, 150mM sodium chloride, 20% glycerol. | ||
| Reactivity life | 12 months | ||
| Note | For reserch purpose only | ||
| Purity | ~95% (SDS-PAGE) | ||
| Description | Retinoblastoma protein-interacting zinc finger protein 1 (RIZ1), also known as PRDM2, is a SAM-dependent histone methyltransferase that specifically methylates histone H3 on lysine 9. RIZ1 contains 8 zinc-finger motifs and 1 PR domain. The RIZ gene encodes two different proteins, RIZ1 and RIZ2. RIZ1 is a tumor suppressor that can arrest the cell cycle and induce apoptosis. RIZ2 however, is a proto-oncoprotein lacking the N-terminal PR domain containing the methyltransferase activity. When RIZ1 is silenced or mutated, the reduced methyltransferase activity can lead to inheritable changes in chromatin methylation and gene expression patterns. Source: Recombinant protein corresponding to aa2-200 from human RIZ1, fused to GST-tag at N-terminal, expressed in E. coli. Molecular Weight: ~49.5kD (aa2-200 + NT GST Tag) Storage and Stability: Aliquot to avoid repeated freezing and thawing and store at -70°C. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap. | ||
© 2020 Imugex All Rights Reserved